![]() |
|
||
---|---|---|
hal-01389959v1
Journal articles
Quadri-lineage disease involving nodal B-cell marginal zone lymphoma, high-grade B-cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia Clinical Case Reports, Wiley, 2015, ⟨10.1002/ccr3.393⟩ ![]() |
||
hal-01389962v1
Journal articles
The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma: Bendamustine-rituximab in nodal MZL Hematological Oncology, Wiley, 2016, ⟨10.1002/hon.2334⟩ |
||
hal-01389960v1
Journal articles
Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA Annals of Hematology, Springer Verlag, 2016, ⟨10.1007/s00277-016-2605-2⟩ |
||
hal-01389963v1
Journal articles
R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma Annals of Hematology, Springer Verlag, 2016, ⟨10.1007/s00277-016-2768-x⟩ |
||
|